Table 3.
Induction of PCOS by androgens and hormones and associated histological alterations
| S. No | Chemical name | Species | Dose | Route & exposure duration | Findings | References | |
|---|---|---|---|---|---|---|---|
| 1 | Estradiol valerate | Wistar Kyoto rat (adult virgin) | 4 mg | Intramuscular injection (single dose) | Many atretic follicles and regressed corpora lutea. | [65] | |
| 2 | Cortisone | B6A mice (neonatal) | 20 μg |
Subcutaneous injection (3–6 days) |
Ovaries lacked corpora lutea and multiple follicular cysts were present. | [66] | |
| 3 | Estrogen | Mice | 20 μg |
Subcutaneous injection (15 days) |
Follicular cysts formed and caused anovulation. Corpora luteum was absent. |
[67] | |
| 4 | Dihydrot-estostero-ne (DHT) | Mice | 250 μg |
Subcutaneous injection (16–18 days of gestation) |
Large number of small antral follicles in ovary, thin granulosa cell layer within follicle and thick theca cell layer. | [43] | |
| 5 | Testoster-one + high fat diet | Wistar rat |
1 mg/ 100 g b.wt |
Subcutaneous injection (28 days) | Many preantral, atretic, and cystic follicles along with enlargement of stroma. | [68] | |
| 6 | Testoster-one | Sprague Dawley rat | 2.5 mg/d | Subcutaneous injection | Increase in cystic, atretic, and preantral follicles. Decrease in corpora lutea. | [69] | |
| 7 | DHT | mice | 10 mg | Subcutaneous implant (90 days) | Numerous multicystic follicles. | [36] | |
| 8 | DHEA + High-fat diet | C57BL/6 Mice |
6 mg/ 100 g b.wt + 60% high-fat diet |
Subcutaneous injection (20 days) + oral diet | More cystic and antral follicles and reduced corpora lutea. | [37] | |
| 9 | Mifeprist-one (Antiprog-esterone) (RU486) | Wistar rat |
5 mg, 7.5 mg, & 10 mg |
Subcutaneous Injection (9 days) |
Enlarged ovaries with arrested follicular development. Increased atretic follicular cysts and hypertrophy of granulosa cells. |
[70] | |
| 10 | Letrozole | C57BL/6N female mice | 50 μg/d | Subcutaneous injection (5 weeks) |
Irregular estrous cycle. Many cysts in ovaries were observed. |
[44] | |
| 11 | Letrozole | Sprague Dawley rats |
1 mg/ kg/d |
Oral (15 days) | Increase in number of cystic and atretic follicles. Decreased corpus luteum and increased thickness of peripheral theca layer. | [71] | |
| 12 | Dehydroe-piandrost-erone (DHEA) | Naval Medical Research Institute (NMRI) rat | 6 mg/kg.b.wt | Intraperitoneal injection (20 days) | Increased number of cystic follicles, decreased number of antral follicles and corpus luteum, and anovulation. | [72] | |
| 13 | Insulin + Human chorionic gonadotr-opin (hCG) | Sprague Dawley rat (70 days old) | Insulin 0.5 to 6 IU/d + hCG3 IU/d | Subcutaneous injection (twice daily for 23 days) | Decrease in luminal epithelial cell numbers and layers, glands and gland conglomerates, and decrease in endometrium and myometrium. | [73] | |
| 14 | DHEA | C57BL/6 mice | 6 mg/100 g.b.wt | Subcutaneous injection (20 days) | Reduction in healthy antral follicles, oocyte, and corpora lutea. Also, granulosa layer of follicles appears thin and degenerated. | [74] | |
| 15 | DHEA | Sprague Dawley rat | 6 mg/100 g.b.wt | Subcutaneous injection (4 weeks) | Increased number of multiple follicular cysts and increased weight of ovary. | [45] | |
| 16 | Human chorionic gonadotr-opin + insulin | Sprague Dawley rat | 3 IU/d (hCG) & 0.5–3 U/d insulin |
Subcutaneous injection (22 days) |
Numerous cystic follicles, degenerated granulosa cell layer, and reduced corpora lutea. | [75] | |
| 17 | DHT | C57Bl/6 J female mice | 10 mg DHT + diets varied in protein, carbs, and fat content | 1 cm SILASTIC brand DHT implant (10 weeks) | Decrease and lack of corpora lutea. | [76] | |
| 18 | Testoster-one | Zebra fish | 0.25, 2, 10, & 100 ng/mL | Dissolved in swimming water (3 days) | Arrest in follicular growth, oligo-ovulation, and ovarian enlargement. | [77] | |
| 19 | DHEA | Sprague Dawley | 7 mg/ kg. b.wt | Subcutaneous injection (90 days) | Higher number of cystic and atretic follicles, hyperthecosis of internal cell layer, and thinning of the ganulosa layer. | [78] | |
| 20 | Estradiol valerate | Wistar rats | 4 mg | subcutaneous injection (single administration) |
Reduction in size of ovary, increased size of cysts, degenerative secondary follicles were present, and Corpus lutea absent. |
[46] | |
| 21 | DHT | Sprague Dawley | 83 µg/d/kg.b.wt | Subcutaneous injection (90 days) | Larger antral follicles, thickened theca interna, multiple cystic follicles lacking antrum and corpus lutea, and reduction in endometrium thickness. | [78] | |